Intra-Cellular Therapies Inc. (ITCI) Slipped -6.08% or -0.95 To Price $14.67 On Tuesday


Intra-Cellular Therapies Inc. (ITCI) slipped -6.08% or -0.95 to $14.67. It is near 74514 shares traded, which is 23.05% compare to the average total volume 323204. The market cap of ITCI is $802.84 million. The year to date change is -3.05%. The 52 week price range is from $14.31 to $25.82. Price of ITCI have changed 2.36% during last week. It have changed -8.33% over last month, -27.11% over last 3 months, -32.26% over last 6 months and 2.90% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ITCI is 18.75. It is 27.81% above current price. The 200-day Moving Averages for ITCI is 20.17. It is 37.49% above current price. The 52-week High is 25.82. It is 76.01% from the current price. The 52-week Low is 14.31. It is -2.45% from current price.

There are some statistics of ITCI. It is has market cap $802.84 million. The share outstanding is 54.73 million. The average volume is 323204. The percent of top 15 Institution holding is 44.70%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ITCI is -43.17%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ITCI is -40.37%.


Tags:

Share this post